Exscientia plc logo

Exscientia plc

NASDAQ:EXAI

Overview | Financials
Company Name Exscientia plc
Symbol EXAI
Currency USD
Price 4.7
Market Cap 590,801,261
Dividend Yield 0%
52-week-range 3.86 - 9.12
Industry Biotechnology
Sector Healthcare
CEO Prof. Andrew L. Hopkins DPHIL, FMEDSCI, FRSE FRSC
Website https://www.exscientia.ai

An error occurred while fetching data.

About Exscientia plc

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to

Related Stocks

Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB

6.02 USD

Prothena Corporation plc logo

Prothena Corporation plc

PRTA

21.65 USD

Veracyte, Inc. logo

Veracyte, Inc.

VCYT

21.78 USD

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

0.927 USD

Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc.

PACB

1.83 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

0.532 USD

Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

CLDX

37.67 USD

CareDx, Inc logo

CareDx, Inc

CDNA

15.13 USD

Financials

Numbers are in millions USD

Numbers are in millions USD